Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods.

<h4>Background</h4>Limited access to drug-susceptibility tests (DSTs) and delays in receiving DST results are challenges for timely and appropriate treatment of multi-drug resistant tuberculosis (TB) in many low-resource settings. We investigated whether data collected as part of routine...

Full description

Bibliographic Details
Main Authors: Shiying You, Melanie H Chitwood, Kenneth S Gunasekera, Valeriu Crudu, Alexandru Codreanu, Nelly Ciobanu, Jennifer Furin, Ted Cohen, Joshua L Warren, Reza Yaesoubi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLOS Digital Health
Online Access:https://doi.org/10.1371/journal.pdig.0000059
_version_ 1797723379124404224
author Shiying You
Melanie H Chitwood
Kenneth S Gunasekera
Valeriu Crudu
Alexandru Codreanu
Nelly Ciobanu
Jennifer Furin
Ted Cohen
Joshua L Warren
Reza Yaesoubi
author_facet Shiying You
Melanie H Chitwood
Kenneth S Gunasekera
Valeriu Crudu
Alexandru Codreanu
Nelly Ciobanu
Jennifer Furin
Ted Cohen
Joshua L Warren
Reza Yaesoubi
author_sort Shiying You
collection DOAJ
description <h4>Background</h4>Limited access to drug-susceptibility tests (DSTs) and delays in receiving DST results are challenges for timely and appropriate treatment of multi-drug resistant tuberculosis (TB) in many low-resource settings. We investigated whether data collected as part of routine, national TB surveillance could be used to develop predictive models to identify additional resistance to fluoroquinolones (FLQs), a critical second-line class of anti-TB agents, at the time of diagnosis with rifampin-resistant TB.<h4>Methods and findings</h4>We assessed three machine learning-based models (logistic regression, neural network, and random forest) using information from 540 patients with rifampicin-resistant TB, diagnosed using Xpert MTB/RIF and notified in the Republic of Moldova between January 2018 and December 2019. The models were trained to predict the resistance to FLQs based on demographic and TB clinical information of patients and the estimated district-level prevalence of resistance to FLQs. We compared these models based on the optimism-corrected area under the receiver operating characteristic curve (OC-AUC-ROC). The OC-AUC-ROC of all models were statistically greater than 0.5. The neural network model, which utilizes twelve features, performed best and had an estimated OC-AUC-ROC of 0.87 (0.83,0.91), which suggests reasonable discriminatory power. A limitation of our study is that our models are based only on data from the Republic of Moldova and since not externally validated, the generalizability of these models to other populations remains unknown.<h4>Conclusions</h4>Models trained on data from phenotypic surveillance of drug-resistant TB can predict resistance to FLQs based on patient characteristics at the time of diagnosis with rifampin-resistant TB using Xpert MTB/RIF, and information about the local prevalence of resistance to FLQs. These models may be useful for informing the selection of antibiotics while awaiting results of DSTs.
first_indexed 2024-03-12T10:02:03Z
format Article
id doaj.art-0deca208cb6846508edc6bbd736c75a7
institution Directory Open Access Journal
issn 2767-3170
language English
last_indexed 2024-03-12T10:02:03Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLOS Digital Health
spelling doaj.art-0deca208cb6846508edc6bbd736c75a72023-09-02T11:33:41ZengPublic Library of Science (PLoS)PLOS Digital Health2767-31702022-01-0116e000005910.1371/journal.pdig.0000059Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods.Shiying YouMelanie H ChitwoodKenneth S GunasekeraValeriu CruduAlexandru CodreanuNelly CiobanuJennifer FurinTed CohenJoshua L WarrenReza Yaesoubi<h4>Background</h4>Limited access to drug-susceptibility tests (DSTs) and delays in receiving DST results are challenges for timely and appropriate treatment of multi-drug resistant tuberculosis (TB) in many low-resource settings. We investigated whether data collected as part of routine, national TB surveillance could be used to develop predictive models to identify additional resistance to fluoroquinolones (FLQs), a critical second-line class of anti-TB agents, at the time of diagnosis with rifampin-resistant TB.<h4>Methods and findings</h4>We assessed three machine learning-based models (logistic regression, neural network, and random forest) using information from 540 patients with rifampicin-resistant TB, diagnosed using Xpert MTB/RIF and notified in the Republic of Moldova between January 2018 and December 2019. The models were trained to predict the resistance to FLQs based on demographic and TB clinical information of patients and the estimated district-level prevalence of resistance to FLQs. We compared these models based on the optimism-corrected area under the receiver operating characteristic curve (OC-AUC-ROC). The OC-AUC-ROC of all models were statistically greater than 0.5. The neural network model, which utilizes twelve features, performed best and had an estimated OC-AUC-ROC of 0.87 (0.83,0.91), which suggests reasonable discriminatory power. A limitation of our study is that our models are based only on data from the Republic of Moldova and since not externally validated, the generalizability of these models to other populations remains unknown.<h4>Conclusions</h4>Models trained on data from phenotypic surveillance of drug-resistant TB can predict resistance to FLQs based on patient characteristics at the time of diagnosis with rifampin-resistant TB using Xpert MTB/RIF, and information about the local prevalence of resistance to FLQs. These models may be useful for informing the selection of antibiotics while awaiting results of DSTs.https://doi.org/10.1371/journal.pdig.0000059
spellingShingle Shiying You
Melanie H Chitwood
Kenneth S Gunasekera
Valeriu Crudu
Alexandru Codreanu
Nelly Ciobanu
Jennifer Furin
Ted Cohen
Joshua L Warren
Reza Yaesoubi
Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods.
PLOS Digital Health
title Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods.
title_full Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods.
title_fullStr Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods.
title_full_unstemmed Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods.
title_short Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods.
title_sort predicting resistance to fluoroquinolones among patients with rifampicin resistant tuberculosis using machine learning methods
url https://doi.org/10.1371/journal.pdig.0000059
work_keys_str_mv AT shiyingyou predictingresistancetofluoroquinolonesamongpatientswithrifampicinresistanttuberculosisusingmachinelearningmethods
AT melaniehchitwood predictingresistancetofluoroquinolonesamongpatientswithrifampicinresistanttuberculosisusingmachinelearningmethods
AT kennethsgunasekera predictingresistancetofluoroquinolonesamongpatientswithrifampicinresistanttuberculosisusingmachinelearningmethods
AT valeriucrudu predictingresistancetofluoroquinolonesamongpatientswithrifampicinresistanttuberculosisusingmachinelearningmethods
AT alexandrucodreanu predictingresistancetofluoroquinolonesamongpatientswithrifampicinresistanttuberculosisusingmachinelearningmethods
AT nellyciobanu predictingresistancetofluoroquinolonesamongpatientswithrifampicinresistanttuberculosisusingmachinelearningmethods
AT jenniferfurin predictingresistancetofluoroquinolonesamongpatientswithrifampicinresistanttuberculosisusingmachinelearningmethods
AT tedcohen predictingresistancetofluoroquinolonesamongpatientswithrifampicinresistanttuberculosisusingmachinelearningmethods
AT joshualwarren predictingresistancetofluoroquinolonesamongpatientswithrifampicinresistanttuberculosisusingmachinelearningmethods
AT rezayaesoubi predictingresistancetofluoroquinolonesamongpatientswithrifampicinresistanttuberculosisusingmachinelearningmethods